Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

10.99
+0.49004.67%
Post-market: 11.250.2593+2.36%19:57 EDT
Volume:1.80M
Turnover:19.56M
Market Cap:683.12M
PE:-8.80
High:11.06
Open:10.51
Low:10.51
Close:10.50
52wk High:11.15
52wk Low:4.50
Shares:62.16M
Float Shares:55.78M
Volume Ratio:2.30
T/O Rate:3.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2490
EPS(LYR):-1.5800
ROE:-24.37%
ROA:-16.41%
PB:2.67
PE(LYR):-6.96

Loading ...

Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago

GlobeNewswire
·
May 11

Sagimet Biosciences Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
May 08

Sagimet Biosciences Inc : Canaccord Genuity Raises Target Price to $49 From $28

THOMSON REUTERS
·
May 05

Sagimet Biosciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 04

Sagimet Biosciences, Inc. Class A (SGMT) Receives a Buy from JonesTrading

TIPRANKS
·
May 04

Oppenheimer Adjusts Price Target on Sagimet Biosciences to $33 From $28, Maintains Outperform Rating

MT Newswires Live
·
May 01

Sagimet Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 30

Sagimet Biosciences price target lowered to $25 from $27 at Guggenheim

TIPRANKS
·
Apr 29

3 Penny Stocks to Watch Now, 4/28/26

TIPRANKS
·
Apr 29

Sagimet Biosciences holds a conference call

TIPRANKS
·
Apr 29

BRIEF-Sagimet Biosciences Offers 29.17 Million Shares Of Series A Common Stock - SEC Filing

Reuters
·
Apr 28

Sagimet Biosciences Inc - Offering 29.17 Mln Shares of Series a Common Stock - SEC Filing

THOMSON REUTERS
·
Apr 28

NASD Most Active Issues

Dow Jones
·
Apr 28

Top Midday Gainers

MT Newswires Live
·
Apr 28

Why Is Sagimet Biosciences Stock Trading Higher On Monday?

Benzinga
·
Apr 28

Sagimet Biosciences Shares Rise With Focus on Acne Treatment

Dow Jones
·
Apr 27

Sagimet Highlights Pipeline Progress and Strategic Corporate Developments

TIPRANKS
·
Apr 27

Sagimet Biosciences Inc - Prices 29.2 Mln Series a Common Shares at $6.00 per Share

THOMSON REUTERS
·
Apr 27

Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock

GlobeNewswire
·
Apr 27

Sagimet plans US Phase 3 denifanstat acne trial start in H2 2026

Reuters
·
Apr 27